The Sickle Cell Disease Market region analysis reveals varying growth opportunities across geographies. North America remains the largest contributor, with strong R&D infrastructure and favorable policies for rare diseases. Europe follows closely due to expanding genetic testing programs. In contrast, Africa and parts of Asia hold significant untapped potential, where improving healthcare...